1. |
Mckelvey MC, Brown R, Ryan S, et al. Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease. Int J Mol Sci, 2021, 22(9): 5018.
|
2. |
Kumar N, Arthur CP, Ciferri C, et al. Structure of the secretory immunoglobulin A core. Science, 2020, 367(6481): 1008-1014.
|
3. |
Bohländer F. A new hope?Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases. Front Immunol, 2023, 14: 1127339.
|
4. |
Sánchez Montalvo A, Gohy S, Rombaux P, et al. The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?Front Allergy, 2022, 3: 852546.
|
5. |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet, 2022, 399(10342): 2227-2242.
|
6. |
Ferrera MC, Labaki WW, Han MK. Advances in Chronic Obstructive Pulmonary Disease. Annu Rev Med, 2021, 72: 119-134.
|
7. |
Wang L, Pelgrim CE, Peralta Marzal LN, et al. Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis. Am J Physiol Lung Cell Mol Physiol, 2022.
|
8. |
Curtis JL. B Cells Caught in the Act: Class Switching to IgA in Lung Lymphoid Follicles in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 2019, 199(5): 548-550.
|
9. |
Yang Y, Palm NW. Immunoglobulin A and the microbiome. Curr Opin Microbiol, 2020, 56: 89-96.
|
10. |
Wei H, Wang JY. Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis. Int J Mol Sci, 2021, 22(5): 2284.
|
11. |
Pan S, Manabe N, Yamaguchi Y. 3D Structures of IgA, IgM, and Components. Int J Mol Sci, 2021, 22(23): 12776.
|
12. |
Saraf S, Jain S, Sahoo RN, et al. Present Scenario of M-Cell Targeting Ligands for Oral Mucosal Immunization. Curr Drug Targets, 2020, 21(12): 1276-1284.
|
13. |
Mao C, Near R, Shibad V, et al. An IgA mimicry of IgG that binds Polymeric Immunoglobulin Receptor for mucosa transcytosis. Antib Ther, 2020, 3(3): 157-162.
|
14. |
Matsuzaki K, Sugimoto N, Islam R, et al. Salivary Immunoglobulin A Secretion and Polymeric Ig Receptor Expression in the Submandibular Glands Are Enhanced in Heat-Acclimated Rats. Int J Mol Sci, 2020, 21(3).
|
15. |
Blackburn JB, Schaff JA, Gutor S, et al. Secretory Cells are the Primary Source of pIgR in Small Airways. Am J Respir Cell Mol Biol, 2022.
|
16. |
Ball M, Hossain M, Padalia D: Anatomy, Airway, StatPearls, Treasure Island (FL): StatPearls PublishingCopyright © 2022, StatPearls Publishing LLC. , 2022.
|
17. |
Onabajo OO, Mattapallil JJ. Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection. Front Immunol, 2021, 12: 657679.
|
18. |
Pietrzak B, Tomela K, Olejnik-Schmidt A, et al. Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells. Int J Mol Sci, 2020, 21(23): 9254.
|
19. |
Mcgrath JJC, Thayaparan D, Cass SP, et al. Cigarette smoke exposure attenuates the induction of antigen-specific IgA in the murine upper respiratory tract. Mucosal Immunol, 2021, 14(5): 1067-1076.
|
20. |
Wyatt TA, Warren KJ, Wetzel TJ, et al. Malondialdehyde-Acetaldehyde Adduct Formation Decreases Immunoglobulin A Transport across Airway Epithelium in Smokers Who Abuse Alcohol. Am J Pathol, 2021, 191(10): 1732-1742.
|
21. |
Polosukhin VV, Richmond BW, Du RH, et al. Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling. Am J Respir Crit Care Med, 2017, 195(8): 1010-1021.
|
22. |
Curtis JL. A Hairline Crack in the Levee: Focal Secretory IgA Deficiency as a First Step toward Emphysema. Am J Respir Crit Care Med, 2017, 195(8): 970-973.
|
23. |
Du RH, Richmond BW, Blackwell TS, Jr. , et al. Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease. Virchows Arch, 2015, 467(6): 657-665.
|
24. |
Di Stefano A, Dossena F, Gnemmi I, et al. Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease. Respir Res, 2022, 23(1): 200.
|
25. |
Sankineni S, Cho Y, Hosseinian N, et al. Does pIgR down-regulation in COPD cause reprogramming of bronchial epithelium?Lung, 2015, 193(1): 1-2.
|
26. |
Prasetyo A, Adi Rahardja A, Tsuroya Azzahro D, et al. Nephrolepis exaltata Herbal Mask Increases Nasal IgA Levels and Pulmonary Function in Textile Factory Workers. Adv Prev Med, 2019, 2019: 5687135.
|
27. |
Richmond BW, Brucker RM, Han W, et al. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency. Nat Commun, 2016, 7: 11240.
|
28. |
Hou J, Sun Y. Role of Regulatory T Cells in Disturbed Immune Homeostasis in Patients With Chronic Obstructive Pulmonary Disease. Front Immunol, 2020, 11: 723.
|
29. |
Richmond BW, Mansouri S, Serezani A, et al. Monocyte-derived dendritic cells link localized secretory IgA deficiency to adaptive immune activation in COPD. Mucosal Immunol, 2021, 14(2): 431-442.
|
30. |
De Fays C, Geudens V, Gyselinck I, et al. Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease. Front Immunol, 2023, 14: 1275845.
|
31. |
Putcha N, Paul GG, Azar A, et al. Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS. PLoS One, 2018, 13(4): e0194924.
|
32. |
Millares L, Martí S, Ardanuy C, et al. Specific IgA against Pseudomonas aeruginosa in severe COPD. Int J Chron Obstruct Pulmon Dis, 2017, 12: 2807-2811.
|